Computed tomographic features of peritoneal carcinomatosis treated by intraperitoneal chemohyperthermia

被引:5
作者
Dromain, C [1 ]
Bisdorff, A [1 ]
Elias, D [1 ]
Antoun, S [1 ]
Boige, V [1 ]
Lasser, P [1 ]
Sigal, R [1 ]
机构
[1] Inst Gustave Roussy, Dept Radiol, F-94805 Villejuif, France
关键词
peritoneum-neoplasm; peritoneum; CT; abdomen-neoplasm; abdomen-CT;
D O I
10.1097/00004728-200305000-00005
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: The purpose of this work was to describe the computed tomography (CT) features of peritoneal carcinomatosis after surgery combined with intraperitoneal chemohyperthermia (IPCH). Method: Between 1999 and 2001, 51 consecutive patients (33 women and 18 men, with a mean age 45 years) were treated in our institution with IPCH for peritoneal carcinomatosis. Patients that were symptomatic (33 patients) underwent contrast enhanced helical CT of the abdomen and the pelvis during the first 15 postoperative days. The CT scans were reviewed retrospectively by two blinded observers. Computed tomography abnormalities were compared with surgical, biochemical, and clinical findings. Results: None of the CT scans were completely normal. Most postsurgical CT findings, including bowel and peritonea] thickening (14 and 13 cases, respectively), increased intraperitoneal fat density (13 cases), and compartmentalized ascites (8 cases), resulted from an inflammatory mesenteric reaction or inflammation of the small bowel or the peritoneum and did not require specific treatment. Major complications requiring appropriate treatment were intra-abdominal abscesses (5 cases), hemoperitoneum (5 cases), urinary fistula (2 cases), acute pancreatitis (1 case) and abdominal wall abscesses (2 cases). Conclusion: Knowledge of early CT findings after therapy with surgery combined with IPCH for peritoneal carcinomatosis is useful for accurate posttreatment management of these patients.
引用
收藏
页码:327 / 332
页数:6
相关论文
共 27 条
[1]  
Antoun S, 2000, B CANCER, V87, P665
[2]  
Beaujard AC, 2000, CANCER-AM CANCER SOC, V88, P2512, DOI 10.1002/1097-0142(20000601)88:11<2512::AID-CNCR12>3.0.CO
[3]  
2-J
[4]   Cytoreduction and intraperitoneal chemotherapy for the management of peritoneal carcinomatosis, sarcomatosis and mesothelioma [J].
Begossi, G ;
Gonzalez-Moreno, S ;
Ortega-Perez, G ;
Fon, LJ ;
Sugarbaker, PH .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2002, 28 (01) :80-87
[5]  
CHU DZJ, 1989, CANCER, V63, P364, DOI 10.1002/1097-0142(19890115)63:2<364::AID-CNCR2820630228>3.0.CO
[6]  
2-V
[7]  
ELIAS D, 1994, HEPATO-GASTROENTEROL, V41, P207
[8]  
Elias D, 2001, CANCER, V92, P71, DOI 10.1002/1097-0142(20010701)92:1<71::AID-CNCR1293>3.0.CO
[9]  
2-9
[10]  
Elias D, 1997, GASTROEN CLIN BIOL, V21, P181